
OMED
Detail Analisis & Profil Saham
Deep AI Analysis
Login untuk Analisis AIAI sedang menyusun analisis mendalam untuk OMED...
Analisis AI Membutuhkan Login
Silakan masuk (login) ke akun Sentix gratis untuk men-generate dan melihat analisis AI mendalam untuk saham OMED.
Masuk / Daftar SekarangTentang Perusahaan
PT Jayamas Medica Industri Tbk manufactures and sells medical devices in Indonesia, the United States of America, and South America. The company operates through three segments: Manufacturing, Distribution, and Retail. It offers medical disposables and consumables comprising medical gloves, syringes, masks, gauze, bandages, urine bag, foley catheter, alcoholic tissue, etc.; antiseptic and disinfectant fluids, povidone iodine, medical alcohol, Hdsol or blood cleansing liquid, etc.; and diagnostics and equipment, such as patient monitor, vital signs monitor, ECG reader, syringe pump, infusion pump, blood pressure monitors, oximeter, fingertip pulse oximeters etc. The company also provides walking aids and rehabilitation care products, including wheelchairs, crutches, walkers, arm slings etc.; biotechnology and laboratory products, such as pregnancy test, PCR test, blood collection tube, PCT tube, chemical reagents, etc; and hospital furniture products comprising patient bed, bed side cabinet, children's patient bed, and operation lamp, as well as wound care products which include plasters, cotton, sterile gauze, etc. In addition, the company engages in warehousing and storage activities; and engages in the manufacturing, selling, and repairs and maintenance of medical devices. It retails medical supplies and equipment through Medicom stores and online platforms. PT Jayamas Medica Industri Tbk was founded in 2000 and is headquartered in Sidoarjo, Indonesia. PT Jayamas Medica Industri Tbk operates as a subsidiary of Pt. Intisumber Hasilsempurna.
Jajaran Direksi
Struktur Kepemilikan
Valuasi Utama
Data Keuangan & Metrik
Indikator Momentum
Volume & Tren MA
Berita Terkini
FTSE Russell: Daftar Saham Indonesia, Rebalancing dan Klasifikasi Market Cap
IHSG melemah 0,07% ke 6.496 pada sesi I Rabu (26/8), ISAT, MEDC, CUAN top losers LQ45
Jayamas Medica (OMED) cetak pertumbuhan laba 43,2%, simak prospeknya
FTSE Tak Tambah Satu Pun Saham Indonesia, 29 Emiten Malah Terdepak
FTSE Russell Ubah Komposisi Saham RI: Puluhan Emiten Keluar Indeks
OMED Raup Penjualan Rp 2,06 Triliun pada 2025
Melantai di Bursa, Saham OMED Dilirik Investor hingga Oversubscribed
Harga Saham Jayamas Medica (OMED) Naik 24,50% pada Hari Pertama Melantai di Bursa
Tidak ada berita Nasional terbaru.
Tidak ada berita Global terbaru.